FIELD: medicine; cardiology.
SUBSTANCE: pharmaceutical composition contains agonist A2A receptor and at least, one base oil, and, at least, one cosolvent.
EFFECT: fast and maximum coronary vasodilatation in mammals without invoking related peripheral vasodilatation, elimination of multiple introduction.
26 cl, 8 ex, 3 tbl, 18 dwg
Authors
Dates
2009-02-20—Published
2004-01-27—Filed